{"id":62333,"date":"2025-12-10T10:03:10","date_gmt":"2025-12-10T09:03:10","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/"},"modified":"2025-12-10T10:03:10","modified_gmt":"2025-12-10T09:03:10","slug":"new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/","title":{"rendered":"New Frontiers for Early-life Nutrition: All G and Armor Prot\u00e9ines Announce Joint Venture to Scale Human and Bovine Lactoferrin as All G Closes A$10 Million Round"},"content":{"rendered":"
\n

SYDNEY–(BUSINESS WIRE)–Australian biotech All G has raised over A$10 million in a convertible note round ahead of its Series B raise, injecting additional capital for commercial-scale production of its first bovine lactoferrin product due to launch in Q1 2026.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nIn parallel, All G and French global bioactives leader Armor Prot\u00e9ines have established a joint venture (JV<\/b>) to produce and commercialise human and bovine lactoferrin.\n<\/p>\n

\nOne of the most powerful functional milk proteins, lactoferrin\u2019s antimicrobial properties and ability to support iron absorption have led to applications across infant nutrition, nutraceuticals, personal care, and therapeutics.\n<\/p>\n

\nThe JV will combine All G\u2019s world-leading precision fermentation platform and deep scientific capabilities, with Armor Prot\u00e9ines\u2019 expertise in high-value, bioactive functional milk proteins, to transform how lactoferrin is made, purchased and consumed. The inclusion of human lactoferrin in the JV represents a pathway to creating infant formulas that more closely reflect the protein profile of breast milk.\n<\/p>\n

\nA new way to meet global lactoferrin demand<\/b>\n<\/p>\n

\nLactoferrin is a multifunctional protein found in both human and cow\u2019s milk. It offers health benefits across the lifespan, playing critical roles in immune function, iron homeostasis, and gastrointestinal and dermatological health.\n<\/p>\n

\nLactoferrin is traditionally extracted from cow\u2019s milk, requiring thousands of litres of milk to yield just one kilogram of lactoferrin. As a result, lactoferrin remains one of the most expensive functional ingredients and is used only in a limited proportion of infant formula products, primarily in premium and super premium formulations.\n<\/p>\n

\nThe development of recombinant lactoferrin as an alternative to animal-based production has long been constrained by technical barriers – notably replicating native glycosylation patterns and achieving yields sufficient for commercial viability. All G has overcome these hurdles, enabling the production of lactoferrin with high purity, consistent quality, scalable production, and ultimately greater global accessibility.\n<\/p>\n

\nBringing human milk proteins to market<\/b>\n<\/p>\n

\nAll G\u2019s human lactoferrin will be bio-equivalent to the native form with greater than 95% purity. As the company\u2019s first recombinant human milk protein, it marks a step toward improving early life nutrition, bringing infant formula closer to the composition of human milk.\n<\/p>\n

\nArmor Prot\u00e9ines\u2019 deep expertise in bioactives, large-scale ingredient manufacturing and commercialization of infant formula ingredients, and long-standing relationships with world-leading nutrition companies position the JV to scale human lactoferrin production rapidly and reliably across global nutrition markets.\n<\/p>\n

\nProgressing quickly to commercial launch<\/b>\n<\/p>\n

\nPilot-scale production of All G\u2019s recombinant bovine lactoferrin is already complete. The company has already self-affirmed GRAS status for adult nutrition sales in the US and approval for personal care sales in China, with further filings underway.\n<\/p>\n

\nAbout All G<\/b>\n<\/p>\n

\nAll G is an Australian biotech developing next-generation human and bovine milk proteins using precision fermentation technology. Focusing on high-value recombinant proteins, the company has filed multiple patents covering its proprietary compositions and processes, including micelle assembly, scalable manufacture, and applications in human milk compositions.\n<\/p>\n

\nAll G\u2019s first product, a bovine lactoferrin powder, will launch in late 2025 and will be followed by human lactoferrin in early 2026.\n<\/p>\n

\nAbout Armor Prot\u00e9ines<\/b>\n<\/p>\n

\nArmor Prot\u00e9ines, a subsidiary of Savencia Fromage & Dairy, is a global producer of lactoferrin, supplying high-purity proteins to the infant formula, adult nutrition, and health supplement industries for over 30 years. Armor Prot\u00e9ines\u2019 long-standing customer relationships, scientific expertise and deep experience in distribution make it a preferred partner for next-generation nutrition ingredients.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nALL G CO PTY LIMITED
\n
723-725 ELIZABETH ST WATERLOO NSW AUSTRALIA 2017
\n
shae@allg.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SYDNEY–(BUSINESS WIRE)–Australian biotech All G has raised over A$10 million in a convertible note round ahead of its Series B raise, injecting additional capital for commercial-scale production of its first bovine lactoferrin product due to launch in Q1 2026. In parallel, All G and French global bioactives leader Armor Prot\u00e9ines have established a joint venture … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62333","6":"format-standard","7":"category-industry"},"yoast_head":"\nNew Frontiers for Early-life Nutrition: All G and Armor Prot\u00e9ines Announce Joint Venture to Scale Human and Bovine Lactoferrin as All G Closes A$10 Million Round - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Frontiers for Early-life Nutrition: All G and Armor Prot\u00e9ines Announce Joint Venture to Scale Human and Bovine Lactoferrin as All G Closes A$10 Million Round - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SYDNEY–(BUSINESS WIRE)–Australian biotech All G has raised over A$10 million in a convertible note round ahead of its Series B raise, injecting additional capital for commercial-scale production of its first bovine lactoferrin product due to launch in Q1 2026. In parallel, All G and French global bioactives leader Armor Prot\u00e9ines have established a joint venture ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-10T09:03:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251209182972\/en\/2666414\/22\/AllG-Logo_DeepBlueHEX_%28002%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"New Frontiers for Early-life Nutrition: All G and Armor Prot\u00e9ines Announce Joint Venture to Scale Human and Bovine Lactoferrin as All G Closes A$10 Million Round\",\"datePublished\":\"2025-12-10T09:03:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\\\/\"},\"wordCount\":604,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251209182972\\\/en\\\/2666414\\\/22\\\/AllG-Logo_DeepBlueHEX_%28002%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\\\/\",\"name\":\"New Frontiers for Early-life Nutrition: All G and Armor Prot\u00e9ines Announce Joint Venture to Scale Human and Bovine Lactoferrin as All G Closes A$10 Million Round - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251209182972\\\/en\\\/2666414\\\/22\\\/AllG-Logo_DeepBlueHEX_%28002%29.jpg\",\"datePublished\":\"2025-12-10T09:03:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251209182972\\\/en\\\/2666414\\\/22\\\/AllG-Logo_DeepBlueHEX_%28002%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251209182972\\\/en\\\/2666414\\\/22\\\/AllG-Logo_DeepBlueHEX_%28002%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Frontiers for Early-life Nutrition: All G and Armor Prot\u00e9ines Announce Joint Venture to Scale Human and Bovine Lactoferrin as All G Closes A$10 Million Round\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Frontiers for Early-life Nutrition: All G and Armor Prot\u00e9ines Announce Joint Venture to Scale Human and Bovine Lactoferrin as All G Closes A$10 Million Round - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/","og_locale":"en_US","og_type":"article","og_title":"New Frontiers for Early-life Nutrition: All G and Armor Prot\u00e9ines Announce Joint Venture to Scale Human and Bovine Lactoferrin as All G Closes A$10 Million Round - Pharma Trend","og_description":"SYDNEY–(BUSINESS WIRE)–Australian biotech All G has raised over A$10 million in a convertible note round ahead of its Series B raise, injecting additional capital for commercial-scale production of its first bovine lactoferrin product due to launch in Q1 2026. In parallel, All G and French global bioactives leader Armor Prot\u00e9ines have established a joint venture ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/","og_site_name":"Pharma Trend","article_published_time":"2025-12-10T09:03:10+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251209182972\/en\/2666414\/22\/AllG-Logo_DeepBlueHEX_%28002%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"New Frontiers for Early-life Nutrition: All G and Armor Prot\u00e9ines Announce Joint Venture to Scale Human and Bovine Lactoferrin as All G Closes A$10 Million Round","datePublished":"2025-12-10T09:03:10+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/"},"wordCount":604,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251209182972\/en\/2666414\/22\/AllG-Logo_DeepBlueHEX_%28002%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/","url":"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/","name":"New Frontiers for Early-life Nutrition: All G and Armor Prot\u00e9ines Announce Joint Venture to Scale Human and Bovine Lactoferrin as All G Closes A$10 Million Round - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251209182972\/en\/2666414\/22\/AllG-Logo_DeepBlueHEX_%28002%29.jpg","datePublished":"2025-12-10T09:03:10+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251209182972\/en\/2666414\/22\/AllG-Logo_DeepBlueHEX_%28002%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251209182972\/en\/2666414\/22\/AllG-Logo_DeepBlueHEX_%28002%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/new-frontiers-for-early-life-nutrition-all-g-and-armor-proteines-announce-joint-venture-to-scale-human-and-bovine-lactoferrin-as-all-g-closes-a10-million-round\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"New Frontiers for Early-life Nutrition: All G and Armor Prot\u00e9ines Announce Joint Venture to Scale Human and Bovine Lactoferrin as All G Closes A$10 Million Round"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62333","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62333"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62333\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62333"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62333"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62333"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}